Association of Enolase-1 with Prognosis and Immune Infiltration in Breast Cancer by Clinical Stage.
Yue-Yu ShiXing-Lei ChenQian-Xin ChenYuan-Zhong YangMeng ZhouYue-Xiang RenLu-Ying TangZe-Fang RenPublished in: Journal of inflammation research (2023)
A higher expression of ENO1 was associated with a better prognosis only in early-stage breast cancer, which may be related to the different effects of ENO1 on immune infiltration, suggesting that ENO1 may be a promising target for precision immunotherapy in breast cancer.